In order to establish long-lasting infections in their mammalian host, filarial nematodes have developed sophisticated strategies to dampen their host’s immune response. Proteins that are actively secreted by the parasites have been shown to induce the expansion of regulatory T cells and to directly interfere with effector T cell function. Here, we analyze the suppressive capacity of Onchocerca volvulus-derived excreted/secreted proteins. Addition of two recombinant O. volvulus proteins, abundant larval transcript-2 (OvALT-2) and novel larval transcript-1 (OvNLT-1) to cell cultures of T cell receptor transgenic CD4+ and CD8+ T cells suppressed antigen-specific stimulation in vitro. Ovalbumin-specific CD4+ DO11.10 and OT-II T cells that had been stimulated with their cognate antigen in the presence of OvALT-2 or OvNLT-1 displayed reduced DNA synthesis quantified by 3H-thymidine incorporation and reduced cell division quantified by CFSE dilution. Furthermore, the IL-2 and IFN-γ response of ovalbumin-specific CD8+ OT-I T cells was suppressed by OvALT-2 and OvNLT-1. In contrast, another recombinant O. volvulus protein, microfilariae surface-associated antigen (Ov103), did not modulate T cell activation, thus serving as internal control for non-ESP-mediated artifacts. Suppressive capacity of the identified ESP was associated with induction of apoptosis in T cells demonstrated by increased exposure of phosphatidylserine on the plasma membrane. Of note, the digestion of recombinant proteins with proteinase K did not abolish the suppression of antigen-specific proliferation although the suppressive capacity of the identified excreted/secreted products was not mediated by low molecular weight contaminants in the undigested preparations. In summary, we identified two suppressive excreted/secreted products from O. volvulus, which interfere with the function of antigen-specific T cells in vitro.
Citation: Hartmann W, Brenz Y, Kingsley MT, Ajonina-Ekoti I, Brattig NW, Liebau E, et al. (2013) Nematode-Derived Proteins Suppress Proliferation and Cytokine Production of Antigen-Specific T Cells via Induction of Cell Death. PLoS ONE 8(6): e68380. https://doi.org/10.1371/journal.pone.0068380
Editor: Hossam M. Ashour, Wayne State University, United States of America
Received: January 2, 2013; Accepted: May 28, 2013; Published: June 21, 2013
Copyright: © 2013 Hartmann et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: This work was funded by the Deutsche Forschungsgemeinschaft grant number PAK 296 BR 1020/4-1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Competing interests: The authors have declared that no competing interests exist.
It is estimated that worldwide more than 1.5 billion people are at risk of being infected with filarial nematodes. Wuchereria bancrofti, Brugia malayi and Onchocerca volvulus are the causative agents of chronic diseases such as lymphatic filariasis and river blindness  and cause a major public health problem. These long-lived parasites have evolved sophisticated strategies to evade the immune response of their host and to survive in the host for more than a decade .
The life cycle of filarial worms in humans and in different animal models is comparable, starting in an arthropod as intermediate host. First stage larvae so called microfilariae (MF) are taken up during a blood meal from a mosquito, blackfly or blood-sucking mite. Within the vector the MF undergo two molts und develop into infective third stage larvae (L3). L3 are transmitted during a second blood meal to their final host. Here, L3 migrate depending on the species to different sides of the body. O. volvulus adults reside in nodules in the subcutaneous tissue while W. bancrofti and B. malayi adults dwell in lymphatic vessels. Different developmental stages have adapted to different niches in the body but utilize similar strategies to promote their survival in their living environment. Chronic helminth infections induce a regulatory network, which is composed of regulatory T cells, alternatively activated macrophages, and anti-inflammatory cytokines . These suppressive cell types might compromise the immune response to the parasite and to unrelated antigens such as vaccines . Impaired proliferation of peripheral T cells to filarial-specific antigens, a phenomenon called lymphocyte hypoproliferation, was already shown in filarial infected humans . Beyond that, pre-existing filarial infection interferes with cellular and humoral immune response to vaccinations such as tetanus toxoid vaccination [6–8].
Using the murine model of human filarial infection, Litomosoides sigmodontis, we have shown recently that concurrent nematode infection suppressed the response to model antigen immunizations and to an experimental vaccination against Plasmodium berghei infection in mice [9,10]. Thereby, L. sigmodontis infection interfered with both, vaccine-induced activation of CD4+ T helper cells and cytotoxic CD8+ T cells in vivo. In general, this helminth-induced immunosuppression depends most likely on the living parasite as drug treatment restored the T cell response . Interaction of helminths with the immune system of their host seems to be mediated by soluble molecules, namely excretory/secretory products (ESP), which are released by live parasites. ESP are biologically active proteins that are either actively exported through secretory pathways or simply leak from the parasite surface . To dissect the composition of ESP, supernatants were collected from in vitro cultured worms and subsequently analyzed by mass spectrometry. Interestingly, a great similarity concerning the protein sequences have been shown for different filarial species such as B. malayi and O. volvulus . Larval stage-specific expression of different proteins was shown for O. volvulus without analyzing the function of these proteins in detail [14,15].
The aim of our study was to analyze selected proteins secreted by O. volvulus in order to identify proteins with immunomodulatory capacity. In this context, ESP derived from the parasitic nematode Heligmosomoides polygyrus have been shown to induce Foxp3+ regulatory T cells in vitro and in vivo  and recombinant cystatin derived from Acantocheilonema vitae suppressed effector T cell function in vitro  and in vivo [18,19]. Recombinant O. volvulus proteins were generated and tested in an in vitro proliferation assay employing T cell receptor (TCR) transgenic T cells. We identified two ESP from O. volvulus that suppressed proliferation of ovalbumin-specific T cells. OvALT-2 and OvNLT-1 diminished proliferation and cytokine secretion of model antigen-specific T cells in vitro while another recombinant ESP, Ov103, displayed no suppressive capacity. We ruled out contaminating endotoxin or toxic low molecular contaminants as suppressive elements in the recombinant ESP preparations. Furthermore, suppressed proliferation was associated with increased induction of cell death but was resistant to proteinase K treatment. Taken together, we identified two new O. volvulus-derived proteins that suppress the function of model antigen-specific T cells in vitro.
Materials and Methods
Animal experimentation was conducted at the animal facility of the Bernhard Nocht Institute for Tropical Medicine in agreement with the German animal protection law under the supervision of a veterinarian. The experimental protocols have been reviewed and accepted by the responsible federal health Authorities of the State of Hamburg, Germany, the "Behörde für Gesundheit und Verbraucherschutz" permission number 98/11. Mice were sacrificed by cervical dislocation under CO2 narcosis. BALB/c mice were purchased from Charles River. OT-II, OT-I and DO11.10 mice were bred in the animal facility of the Bernhard Nocht Institute. Female and male mice were 8-12 weeks of age.
Reagents and antibodies
Anti-CD4-allophycocyanin (clone RM4-5) and Annexin V PE Apoptosis Detection Kit were purchased from eBioscience; CFSE was obtained from Invitrogen (Carlsbad, CA, USA). OVA323-339 was obtained from JPT Peptide Technologies GmbH (Berlin, Germany) and OVA257-264 was purchased from MWG Biotech (Ebersberg, Germany).
Preparation of cDNA from adult O. volvulus
Onchocercomas were derived from studies conducted in Liberia and Ghana [20,21]. Whole worm RNA was prepared from O. volvulus using TRIzol reagent (Invitrogen, Carlsbad, CA, USA) according to the supplier’s protocol. First strand cDNA synthesis was then performed using 2 µg of RNA as template and oligo (dT)18 primers, following the manufacturer’s protocol (Thermo Scientific). Coding sequences were then amplified by PCR using Phusion® High-Fidelity DNA Polymerase (New England Biolabs) following the manufacturer’s instructions.
Cloning, expression and purification of O. volvuluscandidate antigens OvNLT-1, OvALT-2, Ov103, and Ov7
Primers used for PCR are listed in Table S1. Following amplification, the PCR products and the expression vector pJC40  were digested using appropriate FastDigest® restriction enzymes (Thermo Scientific) and ligated using T4 DNA ligase (Invitrogen). 5 µl of each ligation were transformed into XL10-gold ultra competent cells according to the supplier’s protocol (Stratagene). Positive clones were identified by test digestion and sequencing. After transformation of the respective expression plasmids into E. coli Rossetta gami DE3 cells (OvNLT-1) or E. coli BL21DE3 Star cells (OvALT-2, Ov103, Ov7) (Stratagene), expression of the tagged proteins was initiated by the addition of iso-propyl-beta-D-thiogalactopyranoside (IPTG) (0.05 mM IPTG for OvNLT-1, 0.5 mM IPTG for OvALT-2 and 1 mM IPTG for Ov7) once the cultures had reached A600 = 0.5 (OvALT-2, Ov7) or A600 = 0.2(OvNLT-1). Cells were left to grow for additional 3 h (Ov7) or overnight (OvNLT-1, OvALT-2) at 37°C. Expression of Ov103 was carried out by autoinduction . Cells were harvested by centrifugation and the resulting bacterial pellets were resuspended in lysis buffer (50 mM Tris, 500 mM NaCl, 10% glycerol, 0.1% (v/v) Triton X-100, 10 mM imidazole, 1 mM phenylmethylsulfonyl fluoride pH 8.0) for purification of Ov103 and Ov7. For purification of OvNLT-1 and OvALT-2 dithiothreitol (5 mM) was added to the lysis buffer. Pellets were sonicated using a digital sonifier set to 30 watts and 30% amplitude (Branson). The resulting lysate was centrifuged at 10,000 x g for 30 minutes and the supernatant was purified by affinity column chromatography with profinityTM IMAC Ni2+-nitrilotriacetic acid resin (Bio-Rad Laboratories, Germany). Columns were washed with 25 column volumes of washing buffer (lysis buffer containing 20 mM imidazole and 5 mM DTT). The recombinant proteins were eluted with lysis buffer containing 300 mM imidazole (OvNLT-1, OvALT-2, Ov7) or 250 mM imidazole (Ov103) and dialysed in 20 mM Tris buffer, pH 7.5, containing 150 mM NaCl, 0.2 mM DTT, prepared with LPS free water (Aqua B. Braun, Melsungen AG, Germany). The purity of the dialysed proteins was controlled by resolution on 12.5% SDS PAGE and Coomassie blue staining. Proteins were concentrated using Millipore 10,000 MWCO (Amicon Ultra) (6000–8000 MWCO for OvALT-2) and the concentration was determined by the method of Bradford . 60 µg/mL of polymyxin B was added to all stages of purification and the purified proteins and contamination with LPS was quantified using LAL Chromogenic Kit (Limulus Amebocyte Lysate; QCL-1000, Lonza, Walkersville, MD, USA). For proteinase K digestion, 0.05 µg proteinase K per µg recombinant protein were added at the beginning and again after 30 min incubation at 56°C. The digestion was stopped after 60 min by incubation at 75°C for 20 min and 95°C for 20 min. To generate a 3 kDa filtrate the recombinant proteins were centrifuged at 4000 x g using Amicon Ultra-4 Centrifugal Filter Units (3 kDa). The resulting filtrate was checked for remaining protein via SDS-PAGE and Coomassie blue-staining.
In vitro stimulation of lymphocytes and analysis of OVA-specific T cell proliferation
Splenocytes (2 x 105 / well) were cultivated in 96 well round bottom plates for 72 h at 37°C and 5% CO2 in RPMI 1640 medium supplemented with 10% fetal calf serum, L-glutamine (2 mg/mL), HEPES (20 mM) and gentamycin (50 µg/mL). For stimulation, cells were either incubated with medium alone or with to 10 ng/mL OVA323-339 or OVA257-264 peptide alone or in the presence of ESP (2.5–10 µg/mL), digested ESP or 3 kDa filtrate in triplicates. Apoptosis was measured 6 h after in vitro stimulation of spleen cells in the presence of ESP and the cognate antigen. Concentration of IL-2 and IFN-γ in the supernatant of in vitro stimulated OT-I spleen cells was quantified after 72 h culture employing DuoSet ELISA development system kits (R&D Systems, Wiesbaden, Germany) according to the manufacturer´s instructions. Proliferation after 72 h culture of DO11.10 or OT-II spleen cells was either measured by uptake of 3H-thymidine for additional 18 h culture or as carboxyfluorescein diacetate succinimidylester (CFSE) dilution as described before . As CFSE dilution is not as sensitive as 3H-thymidine incorporation we increased the concentration of OVA323-339 peptide 5-fold in order to measure CFSE dilution in vitro (data not shown). For CFSE labeling 5 x 107 spleen cells were resuspended in 10 mL sterile PBS. After addition of 200 µL 50 µM (for in vitro proliferation) or 500 µM (for in vivo proliferation) CFSE cells were incubated for 10 min at 37°C. Labeling reaction was stopped by addition of 40 mL 3% FCS in PBS and cells were washed thrice. For in vitro proliferation CFSE-labeled cells were incubated as described in the previous section. For in vivo proliferation CFSE labeled transgenic OT-II spleen cells (1 x 107) were injected intravenously into C57BL/6 mice as recipients. The day following transfer mice received 50 µg OVA332-339 i.p. in PBS. Half of the mice received an additional injection of 20 µg Ov7 i.p. at the day of the adoptive transfer and one day later. Mice were sacrificed 48 h later, spleen cells isolated and stained with anti-CD4 antibody. Number of proliferation cycles was calculated by CFSE dilution.
Surface staining of spleen cells was performed using anti-CD4 allophycocyanin antibody as described previously . Cell death was analyzed by 7-AAD incorporation and Annexin V phycoerythrin staining according to the manufacturer´s instructions. Samples were analyzed on a FACS Calibur flow cytometer (Becton Dickinson, Mountain View, CA, USA).
Suppression of antigen-specific T cell activation by O. volvulus proteins
To analyze the immunomodulatory capacity of O. volvulus-derived ESP we generated a set of different recombinant proteins in E. coli and purified the proteins via their N-terminal histidine tag. In order to control purity of the protein suspensions SDS-PAGE was performed (Figure 1A).
A) Coomassie blue-staining of recombinant proteins after purification and separation by SDS-PAGE. B) Spleen cells from TCR transgenic DO11.10 (B, C), OT-II (D) or OT-I (E, F) mice were stimulated with 10 ng/mL OVA323-339 (B-D) or OVA257-264 (E, F) peptide in the presence of ESP or LPS in increasing concentrations as indicated on the x-axis. OVA-specific proliferation of DO11.10 (B, C) and OT-II (D) T cells was measured after 72 h as 3H-thymidine incorporation. IL-2 (E) and IFN-γ (F) secretion by OT-I T cells was analyzed by ELISA. Error bars show SD of triplicates. Data shown are representative for five (B, C) or two (D, E, F) independent experiments. Asterisks indicate significant differences in the mean of Ov103 or LPS to Ov7 or OvALT-2 or OvNLT-1 (*** p < 0.001).
Suppressive capacity of the recombinant O. volvulus-derived ESP was analyzed in an in vitro proliferation assay using TCR transgenic mice. In DO11.10 mice all T cells are specific for the OVA323-339 peptide associated with major histocompatibilty complex II (MHC-II) I-Ad . To verify an impact of OvESP on antigen-specific T cell activation DO11.10 spleen cells were stimulated with OVA323-339 in the presence of increasing concentrations of ESP. Proliferation was quantified as DNA synthesis, i.e. 3H-incorporation and was suppressed by co-incubation with the previously described Ov7  (Figure 1B). In addition OvALT-2 and OvNLT-1 suppressed proliferation while Ov103 did not modulate OVA-specific proliferation of DO11.10 T cells (Figure 1C). To demonstrate suppression of T cells carrying a different transgenic TCR, we analyzed antigen-specific proliferation of splenocytes derived from OT-II mice. These mice were generated on the C57BL/6 background and are transgenic for a MHC class II (I-Ab) restricted OVA323–339-specific TCR . Regardless of the genetic background of the T cells, OvALT-2 and OvNLT-1 but not Ov103 suppressed DNA synthesis of OVA-stimulated spleen cells in a dose-dependent manner (Figure 1D).
As Ov proteins were expressed in E. coli, ESP preparations might be contaminated with low amounts of bacterial pathogen-associated molecular patterns (PAMP) such as lipopolysaccharide (LPS). Although suppressive and non-suppressive proteins were prepared in parallel we formally wanted to rule out side effects due to endotoxin contamination. Endotoxin activity as measured by Limulus amebocyte lysate assay was maximally 2.4 EU per µg protein and was comparable in suppressive and non-suppressive protein preparations. We added LPS in increasing concentrations to spleen cell cultures derived from DO11.10 mice and measured OVA-specific T cell proliferation. LPS in the range of 0.1 ng/mL to 100 ng/mL corresponding to 1 EU/mL to 1000 EU/mL did not suppress proliferation of T cells while increasing concentrations of Ov7 abolished T cell proliferation in vitro (Figure 1B).
In addition to the interference of nematode-derived proteins with proliferation of TCR transgenic CD4+ T cells we analyzed the impact on cytokine production by cytotoxic CD8+ T cells. For this purpose, T cells from TCR transgenic OT-I mice that are specific for OVA257-264-peptide in association with MHC class I (H-2Kb) were used . Antigen-specific activation of OT-I spleen cells was measured as IL-2 and IFN-γ cytokine secretion. Addition of both, OvALT-2 and OvNLT-1, decreased secretion of IL-2 and IFN-γcompared to addition of Ov103 as negative control protein (Figure 1E,F). Taken together, we identified OvALT-2 and OvNLT-1 as ESP that suppress proliferation and cytokine secretion by OVA-specific CD4+ T cells and CD8+ T cells derived from TCR transgenic mice.
To directly measure proliferation in addition to DNA synthesis, we labeled OT-II cells with the fluorescent dye CFSE that is diluted upon cell division. After stimulation in the presence of the tested ESP, we gated on CD4+ OT-II T cells and visualized dividing cells by their decreasing CFSE content (Figure 2AB). Thereby we calculated the proportion of dividing cells upon antigen-specific stimulation in the presence of Ov7, OvALT-2 and Ov103 as negative control protein (Figure 2C). OvALT-2 and Ov7 suppressed the antigen-driven division of OVA-specific OT-II T cells whereas Ov103 again did not affect T cell function.
Spleen cells were isolated from OT-II mice and labeled with CFSE. Cells were stimulated with 50 ng/mL OVA323-339 peptide in the presence of nematode-derived proteins Ov103, OvALT-2 or Ov7 in increasing concentrations as indicated on the x-axis. After 72 h cells were stained with anti-CD4 mAb and proliferation of CD4+CFSE+ T cells was analyzed by flow cytometry as percentage of dividing T cells (marker M1). Shown is a representative dot blot of OT-II spleen cells after incubation with 7.5 µg/mL Ov103 (A) or OvALT-2 (B) in the presence of OVA-peptide. C) Graph shows percentage of dividing T cells in the presence of indicated concentration of ESP. Data are presented as the mean of combined results derived from two independent experiments, error bars show SEM. Asterisks indicate significant differences in the mean of Ov103 to Ov7 or OvALT-2, respectively (** p < 0.01; *** p < 0.001).
Limited impact of Ov7 on the clonal expansion of TCR transgenic T cells in vivo
We have shown before that concurrent infection of mice with the filarial nematode L. sigmodontis reduced proliferation of OVA-specific OT-II T cells in vivo . Having identified filarae-derived ESP that suppressed OVA-specific T cell proliferation in vitro, we next wanted to address if these ESP would also suppress T cell proliferation in vivo i.e. mimic the suppressive effect of the ongoing filarial infection. Therefore we adoptively transferred OT-II T cells to syngenic C57BL/6 mice that were treated with 20 µg Ov7 or PBS at the day of the adoptive transfer and one day later. OT-II T cells were stimulated in vivo by injection of the cognate antigen OVA323-339 one day after adoptive transfer and frequencies of OT-II T cells in the spleen were calculated two days later (Figure 3A). Ov7 treatment did not reduce the overall proportion of OT-II T cells in the spleen compared to untreated mice (Figure 3B, p = 0,73). Ov7 treatment slightly interfered with the number of cell divisions undergone by OT-II T cells in vivo (Figure 3C). By trend, a reduced number of OT-II T cells divided three times or more in mice that had been treated with Ov7 compared to untreated mice (p= 0,13). As we did not record statistically significant changes in in vivo T cell proliferation by treatment with the well-defined immunosuppressive ESP Ov7 that we employed as a positive control, we did not repeat these experiments with the undefined new ESP.
CFSE-labeled OT-II spleen cells were adoptively transferred i.v. into C57BL/6 mice. 20 µg Ov7 was injected i.p. at the day of the transfer and one day later. Mice were sacrificed 2 d after in vivo activation with 50 µg OVA323-339 peptide and proliferation was analyzed. A) Representative dot blot showing the gating strategy. We gated on CD4+CFSE+ cells to calculate the frequency of OT-II T cells in the spleen (B) and analyzed the number of cell divisions OT-II T cells have undergone (C). Shown is the frequency of OT-II T cells that did not divide (M0) or divided once (M1), twice (M2), or three times and more (M3) after stimulation in the presence of PBS (white bars) or Ov7 (red bars). Shown are combined results from two independent experiments with six mice per group, error bars show SEM. Analysis with students t test revealed no significant statistical difference of the mean (p = 0,73 (B) and p = 0,13 (C, three and more division cycles). This result was reproduced in two other independent experiment using five control and seven Ov7-treated mice.
OvALT-2- and OvNLT-1-mediated inhibition of OVA-specific proliferation is resistant to proteinase K digestion
Working with proteins that have been expressed in bacteria heat-inactivation is a common control to dissect endotoxin-mediated from protein-mediated effects. To our surprise, heat-inactivation did not abolish the suppressive capacity of the investigated ESP (data not shown and Figure 4C). This may either suggest that suppression was not caused by the ESP but by other constituents in the recombinant protein preparation, or suppressive ESP may function in a heat-stable manner. In order to rule out that decreased proliferation was mediated by low molecular weight E. coli-derived contaminants we separated ESP using a 3 kDa Amicon filter. Ov7 and OvNLT-1 protein preparations (>3 kDa) reproducibly suppressed proliferation of OVA-specific T cells while Ov103 and the low molecular filtrate of all proteins did not alter proliferation (Figure 4A). Thus, we could exclude that toxic low molecular bacterial contaminants in the preparation caused the observed interference with antigen-specific proliferation.
A) ESPs were separated using a 3 kDa Amicon filter into the protein and the "flow through" containing molecules smaller than 3 kDa. Spleen cells derived from DO11.10 mice were labeled with CFSE and stimulated with 10 ng/mL OVA323-339 peptide in the presence of ESP or "flow through". Proliferation was analyzed after 72 h by flow cytometry and is depicted as frequency of dividing CD4+ T cells. B) SDS-PAGE and Coomassie blue staining of recombinant nematode-derived proteins that were either native or digested with proteinase K. C) Thymidine incorporation of DO11.10 cells after incubation with native or proteinase K digested nematode-derived proteins. Shown are results from one experiment representative for two independent repeats. Error bars show SEM of triplicates and asterisks indicate significant differences of the mean (*** p < 0.001).
To test if the suppression of OVA-specific proliferation by nematode-derived proteins OvALT-2 and OvNLT-1 was dependent on the intact protein, we treated proteins with proteinase K. Proteinase K activity in the samples was terminated by heat-inactivation after digestion. Complete digestion of the proteins was confirmed by Coomassie-staining after SDS PAGE (Figure 4B). Unexpectedly, the digested preparations of OvALT-2 and OvNLT-1 still suppressed the OVA-specific proliferation of DO11.10 T cells to the same extent as the corresponding amount of undigested protein (Figure 4C). This T cell suppression by degraded OvALT-2 and OvNLT-1 proteins was not due to cytotoxic products or residual proteinase activity in the reaction as proteinase K treated Ov103 did not suppress DO11.10 T cell proliferation. Therefore, suppression was mediated by heat-stable small fragments of OvNLT-1 and OvALT that were not degraded by proteinase K digestion.
OvALT-2 and OvNLT-1 induce apoptosis in spleen cells
In order to analyze the underlying mechanisms of suppression we measured induction of apoptosis by nematode-derived proteins. To distinguish necrosis and apoptosis, spleen cells were stained with 7-aminoactinomycin (7-AAD) and annexin V. One early feature of apoptosis is indicated by the loss of plasma membrane symmetry and exposure of phosphatidylserine at the outer membrane. Annexin V is a phospholipid-binding protein, which binds to phosphatidylserine on the plasma membrane of early apoptotic cells. Ongoing apoptosis is characterized by complete loss of membrane integrity, allowing intercalation of vital dyes such as 7-AAD in the DNA. By means of 7-AAD and annexin V we distinguished between early apoptotic cells (annexin V+/7-AAD-) and late apoptotic or necrotic cells (annexin V+/7-AAD+). The frequency of apoptotic cells was determined after incubation with recombinant proteins or a 3 kDa filtrate of the same protein preparations to rule out effects induced by putative low molecular weight contaminants (Figure 5A–C). Neither 3 kDa filtrate (flow through) nor the proteins itself altered the proportion of early apoptotic cells in splenic cultures (Figure 5D). In contrast, cells incubated with 5-10 µg/mL OvALT-2 and OvNLT-1 showed a higher proportion of late apoptotic cells after 6 h of incubation (Figure 5E). Thereby 10 µg/mL of OvALT-2 and OvNLT-1 induced apoptosis in almost 100% of the spleen cell culture suggesting that the pro-apoptotic activity of ESPs was not cell type specific. Late apoptosis was not detectable in spleen cells cultured in the presence of the 3 kDa filtrate ruling out that toxic low molecular contaminants in OvALT-2 and OvNLT-1 protein preparations induced apoptosis (Figure 5E). Ov103 did not induce cell death thus showing specificity of OvALT-2- and OvNLT-1-induced suppression.
ESP were separated into protein and "flow through" using Amicon filter. Spleen cells were isolated from BALB/c mice and incubated with increasing concentration of Ov103, OvALT-2 and OvNLT-1 or the corresponding low molecular weight filtrate ("flow through"). After 6 h of incubation cells were stained with 7-AAD and annexin V. Apoptotic cells (annexin V+) were further identified by 7-AAD expression as early apoptotic cells (7-AAD-) or late apoptotic (7-AAD+). Representative dot blots are shown for spleen cells after incubation with 5 µg/mL of nematode-derived Ov103 (A) as control peptide, OvALT-2 (B) or OvNLT-1 (C). Statistical analysis of the frequencies of early (D) and late (E) apoptotic cells. Results show one individual experiment and are representative for two independent experiments.
Taken together, our results identified OvALT-2 and OvNLT-1 as nematode-derived proteins that mediate suppression of antigen-specific T cell activation. Suppressive capacity of the proteins was associated with induction of cell death but was resistant to proteinase K digestion.
In our previous studies we demonstrated that concurrent infection with the pathogenic nematodes L. sigmodontis and Strongyloides ratti suppressed the efficiency of vaccinations to bystander antigens in vivo [9,10,25]. Particularly infection of mice with L. sigmodontis resulted in drastically reduced antibody titer in response to vaccination with a thymus-dependent model antigen. Suppression of B cell response in nematode-infected mice was due to suppression of T helper cell expansion . Moreover, we demonstrated reduced circumsporozoite-specific CD8+ cytotoxic T cell responses upon immunization with a P. berghei-specific vaccine in L. sigmodontis-infected mice compared to non-infected mice . These results are in line with several studies describing the interference of ongoing nematode infections with T cell activation . Screening for nematode products with the potential to suppress T cell activation, several candidates have been described [12,13]. Cystatins derived from O. volvulus and Acanthocheilonema viteae for instance suppressed proliferation of human peripheral blood lymphocytes in vitro  and ameliorated experimental asthma in vivo [18,19].
In the current study we explored the suppressive capacity of ESP derived from the human pathogen O. volvulus. In addition to the well-described Ov7 we identified two ESP that suppressed T cell function in vitro. OvALT-2 and OvNLT-1 suppressed antigen-specific proliferation of two different MHC-II restricted TCR transgenic T cells, OT-II and DO11.10. Moreover, OvALT-2 and OvNLT-1 suppressed antigen-specific IL-2 and IFN-γ production in spleen cell cultures derived from MHC-I-restricted OT-I mice thus indicating a downregulation of both CD4+ and CD8+ T cell function. Several in vitro studies using ESP from different helminth species suggest that one evasion strategy represents the induction of cell death in effector cells [29–32]. Recently, ESP from Fasciola hepatica have been shown to induce apoptosis in eosinophils, a cell type with a central role in the expulsion of helminths . In line with these findings, we demonstrated the induction of cell death in spleen cell cultures upon in vitro exposure to OvALT-2 and OvNLT-1 but not with Ov103.
Working with proteins that are expressed in E. coli, one major concern is a possible contamination with bacterial substances. PAMPs such as LPS might interfere with the activation of OVA-specific T cells. Addition of LPS containing the 10-100 fold endotoxic activity present in our ESP preparations did not modulate T cell proliferation indicating that suppressed proliferation was not due to LPS contamination. To further dissect artificial, E. coli-derived contaminant-mediated effects from protein-mediated suppression we included Ov103. This negative control protein was expressed similarly to the suppressive proteins OvALT-2 and OvNLT-1 and did neither suppress proliferation nor induce cell death in T cells. To exclude suppression mediated by low molecular E. coli-derived toxic contaminants we used Amicon filtration to separate the protein from substances smaller than 3 kDa. Again control protein Ov103 and 3 kDa filtrate of the suppressive proteins OvALT-2 and OvNLT-1 did not change proliferation or induce cell death.
Surprisingly, suppression of OVA-specific T cell proliferation was neither abolished by heat inactivation nor by digestion of the proteins with proteinase K. We controlled complete digestion of the proteins by SDS-PAGE thus ruling out that remaining intact ESP induced observed suppression of proliferation. We excluded interference of the digestion reaction itself with T cell activation, as the digested control protein did not modulate OT-II proliferation. Our results strongly suggest that small peptide fragments derived from OvALT-2 and OvNLT-1 that remained intact after proteinase K digestion and that were not affected by heat-induced disruption of the tertiary structure of the protein would mediate suppression of T cell function. Along this lines suppression of allergic airway inflammation by application of ESP from Heligmosomoides polygyrus during sensitization was not abolished by heat treatment . Moreover, ESP derived from Nippostrongylus brasiliensis inhibited ovalbumin-induced allergy after heat inactivation and proteinase K digestion . As these studies used an undefined ESP concentrate derived from in vitro nematode culture supernatants, the most likely explanation for heat-stable and proteinase-insensitive biologic activity was that immunosuppression was induced by lipids or carbohydrates instead of proteins. Our results, gained with purified recombinant proteins suggest small peptide fragments as additional mediator of proteinase-resistant bioactivity.
However, we cannot formally rule out effects mediated by bacterial-derived toxic proteins in our preparation. It is conceivable that suppressive E. coli-derived non-protein agents might bind selectively to recombinant OvALT-2 and OvNLT-1 but not to Ov103. These contaminants would not be separated by 3 kDa filtration and would be proteinase-resistant. Thus further structural analysis of the recombinant proteins and especially identification of the putative suppressive peptides generated by proteinase K digestion is needed in order to distinguish bacterial- or protein-specific suppression.
Since we observed a strong suppression of the proliferation of TCR transgenic T cells in vitro we asked whether this suppression mimics the inhibitory capacity of nematodes in vivo. In a previous study we showed strong suppression of OVA-specific T cell proliferation after adoptive transfer of OT-II T cells in L. sigmodontis-infected mice . Suppression of OT-II T cell proliferation was less pronounced in mice infected with the intestinal nematode S. ratti . Different parameters such as site and duration of infection most likely contribute to the magnitude of suppression in vivo  and might explain the differences in the suppressive capacity of L. sigmodontis and S. ratti. As ESP from O. volvulus strongly suppressed proliferation of OVA-specific T cell in vitro, we tested, whether these proteins are sufficient to suppress proliferation of OT-II T cells in vivo. After injection of 20 µg of onchocystatin, Ov7, we could not significantly dampen the proliferation of OVA-specific T cells in vivo after adoptive transfer into C57BL/6 mice. This may reflect the limited effect of short-term administration of suppressive ESP in comparison to the continuous secretion by the living parasite. As our positive control protein did not cause significant suppression of proliferation in this experimental setup, we did not attempt to test the suppressive capacity of the other ESP in vivo. To this end, firstly more detailed studies are required concerning the establishment of an ESP application route and regimen sufficient to replace the suppressive capacity of concurrent nematode infection.
Taken together, we identified two O. volvulus-derived proteins, OvALT-2 and OvNLT-1, that act as immunomodulators in vitro and suppress OVA-specific T cell function. Helminths or their secreted products have been shown to protect against autoimmune diseases and allergies in various mouse models . To identify the active compound is a prerequisite to benefit from the therapeutic potential helminths have due to their immunomodulatory capacity. The role of OvALT-2 and OvNLT-1 as potential targets in treating autoimmune diseases need to be further addressed in future studies.
Conceived and designed the experiments: WH MB NB EL. Performed the experiments: WH YB MK . Analyzed the data: MB WH YB MK. Contributed reagents/materials/analysis tools: IH IA-E EL NB. Wrote the manuscript: WH MB.
- 1. Chu BK, Hooper PJ, Bradley MH, McFarland DA, Ottesen EA (2010) The economic benefits resulting from the first 8 years of the Global Programme to Eliminate Lymphatic Filariasis (2000-2007). PLOS Negl Trop Dis 4: e708. doi:10.1371/journal.pntd.0000708. PubMed: 20532228.
- 2. Subramanian S, Stolk WA, Ramaiah KD, Plaisier AP, Krishnamoorthy K et al. (2004) The dynamics of Wuchereria bancrofti infection: a model-based analysis of longitudinal data from Pondicherry, India. Parasitology 128: 467-482. doi:10.1017/S0031182004004822. PubMed: 15180315.
- 3. Maizels RM, Balic A, Gomez-Escobar N, Nair M, Taylor MD et al. (2004) Helminth parasites--masters of regulation. Immunol Rev 201: 89-116. doi:10.1111/j.0105-2896.2004.00191.x. PubMed: 15361235.
- 4. McSorley HJ, Maizels RM (2012) Helminth infections and host immune regulation. Clin Microbiol Rev 25: 585-608. doi:10.1128/CMR.05040-11. PubMed: 23034321.
- 5. Harnett W, Harnett MM (2008) Lymphocyte hyporesponsiveness during filarial nematode infection. Parasite Immunol 30: 447-453. doi:10.1111/j.1365-3024.2008.01045.x. PubMed: 18761488.
- 6. Cooper PJ, Espinel I, Paredes W, Guderian RH, Nutman TB (1998) Impaired tetanus-specific cellular and humoral responses following tetanus vaccination in human onchocerciasis: a possible role for interleukin-10. J Infect Dis 178: 1133-1138. doi:10.1086/515661. PubMed: 9806045.
- 7. Nookala S, Srinivasan S, Kaliraj P, Narayanan RB, Nutman TB (2004) Impairment of tetanus-specific cellular and humoral responses following tetanus vaccination in human lymphatic filariasis. Infect Immun 72: 2598-2604. doi:10.1128/IAI.72.5.2598-2604.2004. PubMed: 15102768.
- 8. Cooper PJ, Espinel I, Wieseman M, Paredes W, Espinel M et al. (1999) Human onchocerciasis and tetanus vaccination: impact on the postvaccination antitetanus antibody response. Infect Immun 67: 5951-5957. PubMed: 10531253.
- 9. Hartmann W, Haben I, Fleischer B, Breloer M (2011) Pathogenic Nematodes Suppress Humoral Responses to Third-Party Antigens In Vivo by IL-10-Mediated Interference with Th Cell Function. J Immunol 187: 4088-4099. doi:10.4049/jimmunol.1004136. PubMed: 21900178.
- 10. Kolbaum J, Tartz S, Hartmann W, Helm S, Nagel A et al. (2011) Nematode-induced interference with the anti-Plasmodium CD8(+) T-cell response can be overcome by optimizing antigen administration. Eur J Immunol.
- 11. Sartono E, Kruize YC, Partono F, Kurniawan A, Maizels RM et al. (1995) Specific T cell unresponsiveness in human filariasis: diversity in underlying mechanisms. Parasite Immunol 17: 587-594. doi:10.1111/j.1365-3024.1995.tb01002.x. PubMed: 8817605.
- 12. Hewitson JP, Grainger JR, Maizels RM (2009) Helminth immunoregulation: the role of parasite secreted proteins in modulating host immunity. Mol Biochem Parasitol 167: 1-11. doi:10.1016/j.molbiopara.2009.04.008. PubMed: 19406170.
- 13. Maizels RM, Blaxter ML, Scott AL (2001) Immunological genomics of Brugia malayi: filarial genes implicated in immune evasion and protective immunity. Parasite Immunol 23: 327-344. doi:10.1046/j.1365-3024.2001.00397.x. PubMed: 11472553.
- 14. Lizotte-Waniewski M, Tawe W, Guiliano DB, Lu W, Liu J et al. (2000) Identification of potential vaccine and drug target candidates by expressed sequence tag analysis and immunoscreening of Onchocerca volvulus larval cDNA libraries. Infect Immun 68: 3491-3501. doi:10.1128/IAI.68.6.3491-3501.2000. PubMed: 10816503.
- 15. Abraham D, Leon O, Leon S, Lustigman S (2001) Development of a recombinant antigen vaccine against infection with the filarial worm Onchocerca volvulus. Infect Immun 69: 262-270. doi:10.1128/IAI.69.1.262-270.2001. PubMed: 11119514.
- 16. Grainger JR, Smith KA, Hewitson JP, McSorley HJ, Harcus Y et al. (2010) Helminth secretions induce de novo T cell Foxp3 expression and regulatory function through the TGF-beta pathway. J Exp Med 207: 2331-2341. doi:10.1084/jem.20101074. PubMed: 20876311.
- 17. Schönemeyer A, Lucius R, Sonnenburg B, Brattig N, Sabat R et al. (2001) Modulation of human T cell responses and macrophage functions by onchocystatin, a secreted protein of the filarial nematode Onchocerca volvulus. J Immunol 167: 3207-3215. PubMed: 11544307.
- 18. Daniłowicz-Luebert E, Steinfelder S, Kühl AA, Drozdenko G, Lucius R et al. (2013) A nematode immunomodulator suppresses grass pollen-specific allergic responses by controlling excessive Th2 inflammation. Int J Parasitol 43: 201-210. doi:10.1016/j.ijpara.2012.10.014. PubMed: 23174104.
- 19. Schnoeller C, Rausch S, Pillai S, Avagyan A, Wittig BM et al. (2008) A helminth immunomodulator reduces allergic and inflammatory responses by induction of IL-10-producing macrophages. J Immunol 180: 4265-4272. PubMed: 18322239.
- 20. Hoerauf A, Mand S, Volkmann L, Büttner M, Marfo-Debrekyei Y et al. (2003) Doxycycline in the treatment of human onchocerciasis: Kinetics of Wolbachia endobacteria reduction and of inhibition of embryogenesis in female Onchocerca worms. Microbes Infect 5: 261-273. doi:10.1016/S1286-4579(03)00026-1. PubMed: 12706439.
- 21. Büttner DW, Albiez EJ, von Essen J, Erichsen J (1988) Histological examination of adult Onchocerca volvulus and comparison with the collagenase technique. Trop Med Parasitol 39 Suppl 4: 390-417. PubMed: 2852393.
- 22. Clos J, Brandau S (1994) pJC20 and pJC40--two high-copy-number vectors for T7 RNA polymerase-dependent expression of recombinant genes in Escherichia coli. Protein Expr Purif 5: 133-137. doi:10.1006/prep.1994.1020. PubMed: 8054844.
- 23. Studier FW (2005) Protein production by auto-induction in high density shaking cultures. Protein Expr Purif 41: 207-234. doi:10.1016/j.pep.2005.01.016. PubMed: 15915565.
- 24. Bradford MM (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72: 248-254. doi:10.1016/0003-2697(76)90527-3. PubMed: 942051.
- 25. Hartmann W, Eschbach ML, Breloer M (2011) Strongyloides ratti infection modulates B and T cell responses to third party antigens. Exp Parasitol, 132: 69–75. PubMed: 21723282.
- 26. Robertson JM, Jensen PE, Evavold BD (2000) DO11.10 and OT-II T cells recognize a C-terminal ovalbumin 323-339 epitope. J Immunol 164: 4706-4712. PubMed: 10779776.
- 27. Bennett SR, Carbone FR, Toy T, Miller JF, Heath WR (1998) B cells directly tolerize CD8(+) T cells. J Exp Med 188: 1977-1983. doi:10.1084/jem.188.11.1977. PubMed: 9841912.
- 28. Taylor MD, van der Werf N, Maizels RM (2012) T cells in helminth infection: the regulators and the regulated. Trends Immunol 33: 181-189. doi:10.1016/j.it.2012.01.001. PubMed: 22398370.
- 29. Serradell MC, Guasconi L, Cervi L, Chiapello LS, Masih DT (2007) Excretory-secretory products from Fasciola hepatica induce eosinophil apoptosis by a caspase-dependent mechanism. Vet Immunol Immunopathol 117: 197-208. doi:10.1016/j.vetimm.2007.03.007. PubMed: 17449115.
- 30. Serradell MC, Guasconi L, Masih DT (2009) Involvement of a mitochondrial pathway and key role of hydrogen peroxide during eosinophil apoptosis induced by excretory-secretory products from Fasciola hepatica. Mol Biochem Parasitol 163: 95-106. doi:10.1016/j.molbiopara.2008.10.005. PubMed: 19028528.
- 31. Guasconi L, Serradell MC, Masih DT (2012) Fasciola hepatica products induce apoptosis of peritoneal macrophages. Vet Immunol Immunopathol 148: 359-363. doi:10.1016/j.vetimm.2012.06.022. PubMed: 22819320.
- 32. Nono JK, Pletinckx K, Lutz MB, Brehm K (2012) Excretory/secretory-products of Echinococcus multilocularis larvae induce apoptosis and tolerogenic properties in dendritic cells in vitro. PLOS Negl Trop Dis 6: e1516. doi:10.1371/journal.pntd.0001516. PubMed: 22363826.
- 33. McSorley HJ, O’Gorman MT, Blair N, Sutherland TE, Filbey KJ et al. (2012) Suppression of type 2 immunity and allergic airway inflammation by secreted products of the helminth Heligmosomoides polygyrus. Eur J Immunol 42: 2667-2682. doi:10.1002/eji.201142161. PubMed: 22706967.
- 34. Trujillo-Vargas CM, Werner-Klein M, Wohlleben G, Polte T, Hansen G et al. (2007) Helminth-derived products inhibit the development of allergic responses in mice. Am J Respir Crit Care Med 175: 336-344. doi:10.1164/rccm.200601-054OC. PubMed: 17122383.
- 35. Helmby H (2009) Helminths and our immune system: friend or foe? Parasitol Int 58: 121-127. doi:10.1016/j.parint.2009.02.001. PubMed: 19223020.
- 36. Elliott DE, Weinstock JV (2012) Helminth-host immunological interactions: prevention and control of immune-mediated diseases. Ann N Y Acad Sci 1247: 83-96. doi:10.1111/j.1749-6632.2011.06292.x. PubMed: 22239614.